[#content_spinnerchief]
Related Posts
First Participant Vaccinated In Pivotal Phase 2/3 Bundibugyo Ebola Vaccine Trial In DRC
- CoreNews Africa
- October 26, 2026
- 0
The first participant has been vaccinated in Tumaini, a pivotal Phase 2/3 clinical trial of vaccine candidates against Bundibugyo virus (BDBV). The vaccination, administered […]